Cephasonics Receives CE Mark Approval for cQuest Cicada Ultrasound Subsystem

Nov 12, 2015, 09:00 ET from Cephasonics

SANTA CLARA, Calif., Nov. 12, 2015 /PRNewswire/ -- Cephasonics, a technology-innovation leader with a flexible, open embedded-ultrasound platform, today announced that it has received CE mark approval for its cQuest Cicada™ subsystem, a 64-channel ultrasound front-end with AutoFocus™ beamforming technology. CE marking indicates compliance with European Union regulations governing medical devices, no matter where in the world they are manufactured, and enables free movement within the European market.

"This is an important milestone and will allow us to accelerate our global commercialization strategy," said Richard Tobias, CEO of Cephasonics. Cephasonics offers a complete ODM network-enabled ultrasound solution to medical, industrial and research customers.

The cQuest Cicada product line is a scalable, full-featured ultrasound platform that offers a high level of flexibility and excellent image quality, enabling fast time to market for customers' end products. The Cicada product line begins with a 64-channel cQEngine hardware platform that is expandable to 256 channels.

The product complies with the essential requirements and exhibits the CE mark for the following equipment categories:

1) Industrial, scientific and medical equipment
2) Medical electrical equipment

By CE marking a product, a manufacturer declares that the product meets all the legal requirements for the CE marking which means that the product can be sold throughout the European Economic Area (EEA), the 28 member states of the EU and European Free Trade Association (EFTA) countries, Iceland, Norway and Liechtenstein.

For additional information, contact info@cephasonics.com.

About Cephasonics

Cephasonics is a medical- and industrial-device technology leader utilizing ultrasound and the power of the cloud to bring about the ubiquitous adoption of ultrasound-based measurement products that improve the quality of life. Launched with a management buyout in March 2012 and headquartered in Santa Clara, Calif., Cephasonics' ultrasound technology, including its AutoFocus™ beamforming technology, has won multiple industry awards for innovation. Additional information about Cephasonics can be found at www.cephasonics.com.

cQuest Cicada and  AutoFocus are trademarks of Cephasonics.

Company Contact:
Judy Kahn
(650) 996-0936


SOURCE Cephasonics